Rev Bras Oftalmol.2012;71(6):394-396

Photodynamic therapy in periocular basal cell carcinoma: case report

Rachel Camargo
Carneiro
, Erick Marcet Santiago de
Macedo
, Pátricia Picciarelli de
Lima
, Suzana
Matayoshi

DOI: 10.1590/S0034-72802012000600011

The authors report the use of photodynamic therapy with methyl aminolevulinate (Metvix®) in a patient with nodular and infiltrative basal cell carcinoma in the right lower eyelid. Side effects on the eye were evaluated weekly. After 12 weeks of treatment, to confirm cure the patient was submitted to a 2-mm punch biopsy, the anatomopathological findings of which were negative for neoplasia. Photodynamic therapy with methyl aminolevulinate was shown to be an attractive alternative to surgical excision¯the current gold standard treatment worldwide.

Photodynamic therapy in periocular basal cell carcinoma: case report

Keywords: ; ; ; ; ;

Comments (0)